Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Oligodendroglioma patient survival is associated with circulating B-cells and age

Neuro-Oncology Advances(2024)10.1093/noajnl/vdae143Source: DataRank Database

Oligodendroglioma patient survival is associated with circulating B-cells and age is a research paper published in Neuro-Oncology Advances (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (24 grants)Impact (FWCI 0.28)OA: goldTopics (44)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Gayathri Warrier ORCID,Helen M. Hansen ORCID,Lucie McCoy ORCID,Terri Rice,Geno Guerra ORCID

Live enrichment

PubMed:39247497 PMC:PMC11379917 OpenAlex:https://openalex.org/W4401714127

National Institutes of Health

Grant: R01CA52689

National Institutes of Health

Grant: P50CA097257

National Institutes of Health

Grant: R01CA126831

National Institutes of Health

Grant: R01CA139020

National Institutes of Health

Grant: R25CA112355

UCSF-CTSI

Grant: UL1 RR024131

NCI NIH HHS

Grant: P30 CA082103

NCCDPHP CDC HHS

Grant: NU58DP006344

NCI NIH HHS

Grant: R01 CA052689

NCI NIH HHS

Grant: T32 CA151022

NCI NIH HHS

Grant: R01 CA266676

National Institutes of Health

Grant: 5R01CA126831-04

Biomarkers of survival in glioma epidemiology

National Institutes of Health

Grant: 5R01CA052689-13

Genetic and Molecular Epidemiology of Adult Glioma

National Institutes of Health

Grant: 3P30CA082103-21S2

Cancer Center Support Grant

National Institutes of Health

Grant: 3UL1RR024131-03S3

Clinical and Translational Science Institute

National Institutes of Health

Grant: 5P50CA097257-12

BRAIN TUMOR SPORT GRANT

National Institutes of Health

Grant: 1R01CA139020-01A1

International Case Control Study of Malignant Glioma

National Institutes of Health

Grant: 5R25CA112355-03

Training in Molecular &Genetic Epidemiology of Cancer

National Center for Advancing Translational Sciences

National Brain Tumor Foundation

Stanley D. Lewis and Virginia S. Lewis Endowed Chair in Brain Tumor Research

Robert Magnin Newman Endowed Chair in Neuro-oncology

Work at University of California, San Francisco

National Center for Research Resources

FWCI

0.28

Citation Percentile

0.6%

Citation Trend

2025

goldLicense: cc-by-nc

journalhttps://academic.oup.com/noa/advance-article-pdf/doi/10.1093/noajnl/vdae143/58850199/vdae143.pdf

publisherhttps://academic.oup.com/noa/advance-article-pdf/doi/10.1093/noajnl/vdae143/58850199/vdae143.pdf

publisherhttps://academic.oup.com/noa/article-pdf/6/1/vdae143/59037241/vdae143.pdf

journalhttps://doi.org/10.1093/noajnl/vdae143

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39247497

Fields of Study

Glioma Diagnosis and TreatmentNeuroinflammation and Neurodegeneration MechanismsCNS Lymphoma Diagnosis and Treatment03 medical and health sciences0302 clinical medicine

Keywords

OligodendrogliomaImmune systemPeripheral bloodMedicineImmunologyDNA methylationOncologyInternal medicineBiologyGliomaCancer researchAstrocytomaGeneticsGeneEpigeneticsImmune FactorsImmunomethylomicsOncology and Carcinogenesis610Rare Diseases (rcdc)Clinical Research (rcdc)Rare DiseasesClinical ResearchBrain Disorders (rcdc)2.1 Biological and endogenous factors32 Biomedical and Clinical Sciences (for-2020)3204 Immunology (for-2020)Neurosciences (rcdc)CancerCancer (rcdc)Brain Cancer (rcdc)Biomedical and Clinical SciencesNeurosciences2.1 Biological and endogenous factors (hrcs-rac)Cancer (hrcs-hc)Brain DisordersBrain Cancer3211 Oncology and Carcinogenesis (for-2020)Basic and Translational Investigations

Sustainable Development Goals

SDG 0: Good health and well-being